Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials

Shao-Huan Lan,Chih-Cheng Lai,Shen-Peng Chang,Chun-Chun Hsu,Cheng-Hsin Chen,Ya-Hui Wang,Yueh Lan Huang,Cheng-Yi Wang,You-Shuei Lin

Journal of Microbiology, Immunology and Infection（2022）

引用 6|浏览19

暂无评分

摘要

Anti-IL-5 therapy was associated with a lower rate of COPD exacerbation compared with placebo. In addition, anti-IL-5 therapy was well tolerated for COPD patients.

查看译文

关键词

COPD,Anti-IL-5,Mepolizumab,Benralizumab,Eosinophil

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要